Well, well....speaking of nefarious *health* directions.....
Pfizer is Buying a Cardiovascular Biopharma Company for $6.7Bn.
https://thenationalpulse.com ^ | December 20, 2021 | by Kay Smythe
Posted on 12/22/2021, 8:18:41 AM by Red Badger
Pfizer is about to buy Arena Pharmaceuticals for $6.7 billion. Arena is a biopharmaceutical company focused in part on cardiovascular and inflammatory medicines to a global patient cohort. A majority of mainstream news outlets have focused their reportage on Arena’s bowel disease treatment, while failing to mention the firm’s cardiovascular research.
Utah-based Arena has existing partnerships with United Therapeutics, who focus their research efforts on pulmonary arterial hypertension. Pfizer’s decision to acquire Arena and their relationship with United Therapeutics is certain to net the company more in return than the bowel disease treatment touted by the corporate press.
Arena’s Crunchbase page also boasts the company’s focus on cardiovascular and inflammatory diseases. A post on their website states the company is “expanding our capabilities to study cardiovascular conditions.”
One of the core issues related to COVID-19 is a predisposition to pulmonary arterial hypertension.
COVID-19 vaccinations have also been heavily linked to cardiovascular issues such as myocarditis, especially in young men. Though a majority of the mainstream news media’s reportage has focused on Moderna’s mRNA vaccine for COVID-19 and links to myocarditis, Pfizer’s COVID-19 vaccine has also been linked to the heart condition. ...
https://freerepublic.com/focus/news/4023432/posts?page=1
~~~~~
Create the product that causes health issues, own the company that makes a ‘solution’ to said problem.
These people are evil!
Good morning, TFT!
Yep
Good morning, Jane!
Evil is putting it mildly.
Waiting for hubby to get up so we can make Banana Nut Bread together.
Isn’t that sweet? He likes to help.
I think they have passed evil, and are into diabolical.